|
JP2019077684A
|
|
Npy neuron activator and ghrelin resistant anorexia improving agent
|
|
JP2019010098A
|
|
Flavor deterioration inhibitor and flavor deterioration inhibition method
|
|
JP2018077238A
|
|
Dementia-improving agent, determination method, and kit
|
|
JP2018062488A
|
|
Ghrelin signaling enhancer and food composition for enhancing ghrelin signaling
|
|
JP2017071600A
|
|
Smoldering inflammation inhibitor
|
|
JP2018008898A
|
|
Anticancer agent, radiosensitizer, and food composition
|
|
JP2016204310A
|
|
Neurite outgrowth inhibitor, pain inhibitor, and itch inhibitor
|
|
JP2016204274A
|
|
Acetylcholine esterase inhibitor
|
|
JP2015205858A
|
|
Neurite outgrowth inhibitor, pain inhibitor and itch inhibitor
|
|
JP2015168646A
|
|
Dementia-improving agent, determination method, and kit
|
|
JP2014224085A
|
|
Anticancer drug for cancer stem cell
|
|
JP2013234178A
|
|
Cell death-inhibiting composition
|
|
JP2014201528A
|
|
Antioxidant
|
|
JP2014189539A
|
|
Aromatase inhibitor
|
|
JP2013177384A
|
|
Keratin releasing composition
|
|
JP2014114250A
|
|
Xanthine oxidase inhibitor composition containing garcinia esculenta extract
|
|
JP2014008038A
|
|
Method for producing swell symptom model animal and method for evaluating swell curative medicine
|
|
JP2012126716A
|
|
Composition effective for prevention and treatment of dementia, and chinese/crude medicine preparation containing the same
|
|
JP2012152116A
|
|
Method for measuring number of viable cell in crude drug
|
|
JP2012145520A
|
|
Evaluation method for warming up effect from inside of body
|
